002462.SZ
嘉事堂
SZSE · Healthcare · F 批发零售 · CN
CNY 11.96
−1.16%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 18.8B | 19.5B | 24.0B | 30.0B | 26.2B |
| Cost of Revenue | 17.7B | 18.3B | 22.4B | 28.0B | 24.1B |
| Gross Profit | 1.2B | 1.2B | 1.6B | 2.0B | 2.1B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 258.3M | 271.7M | 363.9M | 326.6M | 318.6M |
| Selling & Marketing Expense | 251.1M | 261.6M | 518.9M | 724.9M | 834.8M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 607.3M | 641.8M | 1.1B | 1.2B | 1.4B |
| Cost and Expenses | 18.3B | 18.9B | 23.5B | 29.3B | 25.5B |
| Operating Income (EBIT) | 251.5M | 281.7M | 568.1M | 556.4M | 650.1M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 247.8M | 278.1M | 546.7M | 555.3M | 644.9M |
| Income Tax Expense | 169.5M | 176.4M | 230.0M | 178.7M | 176.6M |
| Bottom Line | |||||
| Net Income | 103.3M | 111.4M | 158.1M | 250.1M | 296.9M |
| Earnings from Cont. Ops | 78.3M | 101.7M | 316.7M | 376.5M | 468.3M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 103.3M | 111.4M | 158.1M | 250.1M | 296.9M |
| Per Share | |||||
| Basic EPS | CN¥0.35 | CN¥0.38 | CN¥0.54 | CN¥0.86 | CN¥1.02 |
| Diluted EPS | CN¥0.35 | CN¥0.38 | CN¥0.54 | CN¥0.86 | CN¥1.02 |
| Revenue Per Share | CN¥64.24 | CN¥66.62 | CN¥82.02 | CN¥103.16 | CN¥90.07 |
| Shares | |||||
| Basic Shares Outstanding | 292.9M | 293.1M | 292.8M | 290.8M | 291.1M |
| Diluted Shares Outstanding | 292.9M | 293.1M | 292.8M | 290.8M | 291.1M |
| Profitability Metrics | |||||
| EBITDA | — | 323.7M | 653.4M | 768.6M | 861.6M |
| D&A | — | 42.0M | 85.3M | 212.2M | 211.5M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026